Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
69 1.4% |
 |
Eli Lilly and CompanyLLY |
83 0% |
 |
PfizerPFE |
52 1.9% |
 |
AbbVieABBV |
77 0% |
 |
TherapeuticsMDTXMD |
24 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Nov 2024 | 82 | |
| Oct 2024 | 82 | |
| Sep 2024 | 83 | |
| Aug 2024 | 83 |
How do employees feel about the future at Astrazeneca?
The Business Outlook at Astrazeneca is positive according to its employees. The average outlook rating 81 (out of 100) is high. But this rating, aggregated from the top review sites in the US, is down by -1.2% since the last month.
Analyzing Business Outlook, how is Astrazeneca performing compared to its industry peers?
Astrazeneca overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 81st percentile.
How has the business outlook at Astrazeneca changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Astrazeneca.
Why is it important to track the business outlook at Astrazeneca?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Astrazeneca.
